NasdaqCM - Delayed Quote USD
Turnstone Biologics Corp. (TSBX)
0.3276
+0.0055
+(1.71%)
At close: May 30 at 4:00:00 PM EDT
0.3126
-0.01
(-4.58%)
After hours: May 30 at 5:24:05 PM EDT
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Sammy J. Farah M.B.A., Ph.D. | President, CEO & Director | 631.45k | -- | 1973 |
| Ms. Saryah Azmat | COO & Corporate Secretary | 426.9k | -- | 1990 |
| Ms. Wendy Worcester CFA, CPA | VP, Principal Finance & Accounting Officer | -- | -- | -- |
| Dr. David Stojdl Ph.D. | Senior Vice President of Research & Discovery | -- | -- | -- |
| Dr. Ines Verdon M.D. | Senior Vice President of Clinical Development | -- | -- | -- |
| Dr. Michael Fitch Ph.D. | Senior Vice President of Manufacturing | -- | -- | -- |
Turnstone Biologics Corp.
9310 Athena Circle
Suite 300
San Diego, CA 92037
United States
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 8
Description
Turnstone Biologics Corp. operates as a biotechnology company. The company was founded in 2014 and is headquartered in San Diego, California.
Corporate Governance
Turnstone Biologics Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Related Tickers
SNSE Sensei Biotherapeutics, Inc.
0.3015
+0.50%
RLYB Rallybio Corporation
0.3090
-3.13%
DMN.MU Diamyd Medical AB
0.8090
-0.86%
BZYR Burzynski Research Institute, Inc.
0.0310
-11.43%
ELDN Eledon Pharmaceuticals, Inc.
3.0000
-2.91%
ESLA Estrella Immunopharma, Inc.
1.0096
+0.96%
2160.T GNI Group Ltd.
4,290.00
+5.80%
ACXP Acurx Pharmaceuticals, Inc.
0.3886
+0.15%
NXTC NextCure, Inc.
0.4924
-0.85%
CLCS Cell Source, Inc.
0.2400
-13.85%